Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer (Q34156759)

31 July 2017

1 reference

title

Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer (English)

1 reference

31 July 2017

main subject

phase I clinical trial

0 references

author name string

Margolis DJ

series ordinal

1

1 reference

31 July 2017

Crombleholme T

series ordinal

2

1 reference

31 July 2017

Herlyn M

series ordinal

3

1 reference

31 July 2017

publication date

1 November 2000

1 reference

Wound Repair and Regeneration

31 July 2017

published in

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

480-493

1 reference

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Epidemiology of lower-extremity amputations in the Indian Health Service, 1982-1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

The description and classification of diabetic foot lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Chronic cutaneous ulcers: etiology and epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Cost of diabetes-related amputations in minorities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Risk factors for amputation in patients with diabetes mellitus. A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Aetiology of Diabetic Foot Ulceration: A Role for the Microcirculation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressure ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Management of chronic venous leg ulcers: a literature-guided approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

A systematic review of compression treatment for venous leg ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Wound healing--aiming for perfect skin regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Pharmacologic enhancement of wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

The basic science of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Gene therapy: adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Recombinant adenoviral mediated gene transfer in ischemic impaired wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-475X.2000.00480.X

10.1046/J.1524-475X.2000.00480.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference